Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Diabetes. 2017 Dec 21;10(4):276–285. doi: 10.1111/1753-0407.12618

Table 3.

Spearman’s correlation coefficients and summary statistics from linear (Deming) regression (unadjusted) for HbA1c or fasting glucose on glycated albumin or fructosamine stratified by CKD category and anemia status

CKD categories With anemia
N=525
Without anemia
N=1,140


Spearman’s r Deming Regression Spearman’s r Deming Regression


Intercept Slope RMSE Intercept Slope RMSE
HbA1c, % (X) and fasting glucose, mmol/L (Y) No CKD 0.59 −12.84 3.00 0.72 0.70 −7.93 2.36 0.69
Moderate CKD 0.62 −9.33 2.48 0.72 0.64 −8.57 2.40 0.85
Severe CKD 0.53 −16.20 3.48 0.89 0.52 −10.11 2.65 0.91
Very Severe CKD 0.35 −12.78 2.89 1.15 0.67 −12.60 3.02 0.76

Glycated albumin, % (X) and fasting glucose, mmol/L (Y) No CKD 0.48 0.12 0.44 1.52 0.56 2.11 0.34 1.47
Moderate CKD 0.51 2.12 0.32 1.57 0.50 0.46 0.45 1.87
Severe CKD 0.40 3.27 0.23 1.67 0.41 0.50 0.45 1.90
Very Severe CKD 0.29 3.71 0.19 2.09 0.53 −1.23 0.57 1.79

Fructosamine, umol/L (X) and fasting glucose, mmol/L (Y) No CKD 0.49 0.90 0.02 1.68 0.54 1.59 0.02 1.55
Moderate CKD 0.54 1.13 0.02 1.62 0.54 −1.06 0.03 1.95
Severe CKD 0.43 3.29 0.01 1.71 0.41 0.35 0.03 2.10
Very Severe CKD 0.28 3.90 0.01 2.16 0.50 −0.72 0.03 2.08

Glycated albumin, % (X) and HbA1c, % (Y) No CKD 0.67 3.01 0.23 0.63 0.68 2.97 0.23 0.57
Moderate CKD 0.72 3.44 0.20 0.63 0.72 2.50 0.27 0.63
Severe CKD 0.63 3.47 0.19 0.68 0.74 2.43 0.27 0.62
Very Severe CKD 0.72 2.95 0.22 0.75 0.71 2.91 0.24 0.69

Fructosamine, umol/L (X) and HbA1c, % (Y) No CKD 0.61 2.79 0.01 0.72 0.64 2.22 0.02 0.66
Moderate CKD 0.68 2.65 0.02 0.70 0.67 1.19 0.02 0.74
Severe CKD 0.55 3.09 0.01 0.75 0.64 1.61 0.02 0.79
Very Severe CKD 0.64 2.05 0.02 0.83 0.62 2.59 0.02 0.85

Anemia was defined using sex-specific cut-points of hemoglobin 130 g/l for men and 120 g/l for women.

Note: Chronic kidney disease staging was done using the KDIGO 2012 guidelines with eGFR and albumin-to-creatinine ratio.